Ampicillin
Omnipen-n, Penbritin-s, Polycillin-n, Totacillin-n, Unasyn (ampicillin) is a small molecule pharmaceutical. Ampicillin was first approved as Polycillin-n on 1982-01-01. It is used to treat actinomycosis, bacillary dysentery, bacterial endocarditis, bacterial infections, and bacterial meningitis amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
infections | D007239 |
digestive system diseases | D004066 |
respiratory tract diseases | D012140 |
nervous system diseases | D009422 |
urogenital diseases | D000091642 |
cardiovascular diseases | D002318 |
skin and connective tissue diseases | D017437 |
signs and symptoms pathological conditions | D013568 |
wounds and injuries | D014947 |
Trade Name
FDA
EMA
Combinations
Unasyn (generic drugs available since 1982-01-01)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ampicillin sodium
Ampicillin sodium
+
Sulbactam sodium
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
UNASYN | Mylan | N-050608 RX | 1986-12-31 | 3 products, RLD, RS |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
ampicillin and sulbactam | ANDA | 2023-05-30 |
unasyn | New Drug Application | 2023-03-29 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
actinomycosis | EFO_0007128 | D000196 | A42 |
bacillary dysentery | — | D004405 | A03 |
bacterial endocarditis | EFO_1000830 | D004697 | — |
bacterial infections | — | D001424 | A49 |
bacterial meningitis | EFO_1000831 | D016920 | G00 |
bacterial skin diseases | — | D017192 | — |
escherichia coli infections | EFO_1001318 | D004927 | B96.20 |
gonorrhea | DOID_7551 | D006069 | A54 |
haemophilus infections | EFO_1001127 | D006192 | — |
human bites | — | D001734 | W50.3 |
Show 11 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01C: Beta-lactam antibacterials, penicillins
— J01CA: Penicillins with extended spectrum
— J01CA01: Ampicillin
— J01CA51: Ampicillin, combinations
— J01CR: Combinations of penicillins, incl. beta-lactamase inhibitors
— J01CR01: Ampicillin and beta-lactamase inhibitor
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AA: Antibiotics, ophthalmologic
— S01AA19: Ampicillin
Clinical
Clinical Trials
99 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Malaria | D008288 | EFO_0001068 | B54 | 5 | 13 | 26 | 22 | 8 | 67 |
Falciparum malaria | D016778 | EFO_0007444 | B50 | 1 | 3 | 6 | 15 | 2 | 27 |
Anemia | D000740 | EFO_0004272 | D64.9 | — | — | 2 | 1 | 3 | 6 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Vivax malaria | D016780 | EFO_0007445 | B51 | — | — | 2 | — | 1 | 3 |
Fever | D005334 | HP_0001945 | R50.9 | — | — | 1 | — | 1 | 2 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | 2 | — | — | 2 |
Respiratory tract infections | D012141 | J06.9 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | 2 | 1 | — | — | — | 2 | ||
Healthy volunteers/patients | — | 2 | 1 | — | — | — | 2 | ||
Covid-19 | D000086382 | U07.1 | — | 1 | — | — | — | 1 | |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | 1 | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | — | — | — | — | 1 | 1 |
Schistosomiasis | D012552 | EFO_1001475 | B65 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | AMPICILLIN |
INN | ampicillin |
Description | Ampicillin is a penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group. It has a role as an antibacterial drug. It is a penicillin, a penicillin allergen and a beta-lactam antibiotic. It is a conjugate acid of an ampicillin(1-). |
Classification | Small molecule |
Drug class | penicillins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O |
Identifiers
PDB | — |
CAS-ID | 69-53-4 |
RxCUI | 221058 |
ChEMBL ID | CHEMBL174 |
ChEBI ID | 28971 |
PubChem CID | 6249 |
DrugBank | DB00415 |
UNII ID | 7C782967RD (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 159,768 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
32 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more